These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3382760)

  • 1. Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study.
    Gamba G; Solerte SB; Grignani G; Pacchiarini L; Montani N; Ferrari E
    Blut; 1988 Jun; 56(6):257-60. PubMed ID: 3382760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus.
    García Frade LJ; de la Calle H; Torrado MC; Lara JI; Cuellar L; García Avello A
    Thromb Res; 1990 Jul; 59(1):51-9. PubMed ID: 2119076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes mellitus and fibrinolysis (experience with an in vitro clot lysis test)].
    Udvardy M; Pósán E
    Orv Hetil; 1994 Sep; 135(37):2025-7. PubMed ID: 7936609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemostasis and lipid metabolism in patients with non-insulin- dependent diabetes mellitus and angiopathy of the lower extremities].
    Mamedgasanov RM; Semavin IE; Smirnova LM; Rudenko GR; Riazanov IuI
    Klin Med (Mosk); 1989 Aug; 67(8):74-6. PubMed ID: 2811244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid metabolism and fibrinolysis in diabetic nephropathy in the course of diabetes type II].
    Małyszko J; Małyszko J; Mazerska M; Myśliwiec M
    Pol Arch Med Wewn; 1995 Oct; 94(4):324-30. PubMed ID: 8834126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Some parameters of hemostasis and fibrinolysis in diabetic patients].
    Telejko B; Zonenberg A; Borejszo I; Kinalska I
    Pol Arch Med Wewn; 1998 Aug; 100(2):133-8. PubMed ID: 10101928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma lipids and microangiopathy in insulin-dependent diabetes mellitus.
    Eckel RH; McLean E; Albers JJ; Cheung MC; Bierman EL
    Diabetes Care; 1981; 4(4):447-53. PubMed ID: 7049628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinolysis in diabetes mellitus. Role of overweight and hypertriglyceridemia.
    Cucuianu M; Fekete T; Marcusiu C; Mösler R; Duţu A
    Med Interne; 1984; 22(3):171-7. PubMed ID: 6494764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of LDL to lipid peroxidation in non-insulin-dependent diabetes mellitus with or without macroangiopathy].
    Gallou G; Ruelland A; Campion L; Allannic H; Legras B; Cloarec L
    Ann Biol Clin (Paris); 1994; 52(10):695-9. PubMed ID: 7747876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
    O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
    Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation profile in diabetes and its association with diabetic microvascular complications.
    Madan R; Gupt B; Saluja S; Kansra UC; Tripathi BK; Guliani BP
    J Assoc Physicians India; 2010 Aug; 58():481-4. PubMed ID: 21189694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude of dyslipedemia and its association with micro and macro vascular complications in type 2 diabetes: a hospital based study from Bikaner (Northwest India).
    Agrawal RP; Sharma P; Pal M; Kochar A; Kochar DK
    Diabetes Res Clin Pract; 2006 Aug; 73(2):211-4. PubMed ID: 16580758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.
    Laakso M; Pyörälä K; Voutilainen E; Marniemi J
    Am J Epidemiol; 1987 Apr; 125(4):611-21. PubMed ID: 3548333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of improved post-prandial blood glucose control on post-prandial metabolism and markers of vascular risk in people with Type 2 diabetes.
    Gallagher A; Home PD
    Diabetes Res Clin Pract; 2005 Mar; 67(3):196-203. PubMed ID: 15713351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus.
    Lehto S; Niskanen L; Suhonen M; Rönnemaa T; Laakso M
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):978-83. PubMed ID: 8696962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.